SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-000801
Filing Date
2020-02-14
Accepted
2020-02-14 06:36:58
Documents
14
Period of Report
2020-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20191101x8kaa42b3c.htm   iXBRL 8-K 34951
2 EX-99.1 ex-99d1.htm EX-99.1 264461
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 158550
  Complete submission text file 0001558370-20-000801.txt   651144

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20191101.xsd EX-101.SCH 3039
5 EX-101.LAB imgn-20191101_lab.xml EX-101.LAB 16755
6 EX-101.PRE imgn-20191101_pre.xml EX-101.PRE 9902
14 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20191101x8kaa42b3c_htm.xml XML 4646
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 20613712
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences